By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche NimbleGen today said that it has named Macrogen a Certified Service Provider for Korea.

Specifically, Macrogen has joined the CSP program for offering services using NimbleGen's Comparative Genomic Hybridization/Copy Number Variation services in its lab in Seoul, South Korea. Macrogen will process gDNA samples for CGH/CNV using the complete NimbleGen array CGH workflow including the high-resolution MS 200 Microarray Scanner.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.